FibroGen's GAAP loss for 6M 2021 was $206.066 million, up 25.9% from $163.661 million in the previous year. Revenue decreased 6.7% to $62.793 million from $67.288 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept